Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NOXA‐mediated degradation of MCL1 and BCL2L1 causes apoptosis of daunorubicin‐treated human acute myeloid leukemia cells
Jing‐Ting Chiou, Nan‐Chieh Huang, Chia‐Hui Huang, et al.
Journal of Cellular Physiology (2021) Vol. 236, Iss. 11, pp. 7356-7375
Closed Access | Times Cited: 21

Showing 21 citing articles:

Src inhibition potentiates MCL-1 antagonist activity in acute myeloid leukemia
Xiaoyan Hu, Lin Li, Jewel Nkwocha, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1
LILRB2 inhibition enhances radiation sensitivity in non-small cell lung cancer by attenuating radiation-induced senescence
Xiaozheng Chen, Meng Yuan, Zhong Tao, et al.
Cancer Letters (2024) Vol. 593, pp. 216930-216930
Open Access | Times Cited: 6
Cycloastragenol induces apoptosis and protective autophagy through AMPK/ULK1/mTOR axis in human non-small cell lung cancer cell lines
Lihua Zhu, Yupei Liang, Lian Yang, et al.
Journal of Integrative Medicine (2024) Vol. 22, Iss. 4, pp. 503-514
Open Access | Times Cited: 5
Noxa inhibits oncogenesis through ZNF519 in gastric cancer and is suppressed by hsa-miR-200b-3p
Jin Shi, Fan Ding, Dezhu Dai, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
BCL-2 dependence is a favorable predictive marker of response to therapy for chronic lymphocytic leukemia
Stephen Jun Fei Chong, Junyan Lu, Rebecca Valentin, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
BCL2 inhibitor ABT-199 and BCL2L1 inhibitor WEHI-539 coordinately promote NOXA-mediated degradation of MCL1 in human leukemia cells
Jing‐Ting Chiou, Yuan‐Chin Lee, Liangjun Wang, et al.
Chemico-Biological Interactions (2022) Vol. 361, pp. 109978-109978
Closed Access | Times Cited: 16
Targeting CD19-positive lymphomas with the antibody-drug conjugate loncastuximab tesirine: preclinical evidence as single agent and in combination therapy
Chiara Tarantelli, David N. Wald, Nicolas Munz, et al.
Haematologica (2024) Vol. 109, Iss. 10, pp. 3314-3326
Open Access | Times Cited: 3
Amsacrine downregulates BCL2L1 expression and triggers apoptosis in human chronic myeloid leukemia cells through the SIDT2/NOX4/ERK/HuR pathway
Yuan‐Chin Lee, Jing‐Ting Chiou, Liangjun Wang, et al.
Toxicology and Applied Pharmacology (2023) Vol. 474, pp. 116625-116625
Closed Access | Times Cited: 7
Simultaneous Inhibition of Mcl-1 and Bcl-2 Induces Synergistic Cell Death in Hepatocellular Carcinoma
M Michalski, Magdalena Bauer, Franziska Walz, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1666-1666
Open Access | Times Cited: 6
Cytarabine-induced destabilization of MCL1 mRNA and protein triggers apoptosis in leukemia cells
Jing‐Ting Chiou, Chia‐Chi Hsu, Ying-Chung Hong, et al.
Biochemical Pharmacology (2023) Vol. 211, pp. 115494-115494
Closed Access | Times Cited: 5
Regulation of P-glycoprotein by miR-27a-3p at the Brain Endothelial Barrier
Saba Hammad, Aloı̈se Mabondzo, Rifat Hamoudi, et al.
Journal of Pharmaceutical Sciences (2021) Vol. 111, Iss. 5, pp. 1470-1479
Open Access | Times Cited: 11
Synergistic cytotoxicity of decitabine and YM155 in leukemia cells through upregulation of SLC35F2 and suppression of MCL1 and survivin expression
Jing‐Ting Chiou, Long‐Sen Chang
APOPTOSIS (2023) Vol. 29, Iss. 3-4, pp. 503-520
Closed Access | Times Cited: 4
NRF2 activation in BON‑1 neuroendocrine cancer cells reduces the cytotoxic effects of a novel Ruthenium(II)‑curcumin compound: A pilot study
Alessia Garufi, Riccardo Pettinari, Laura Monteonofrio, et al.
Oncology Reports (2024) Vol. 51, Iss. 2
Closed Access | Times Cited: 1
Oncogenic Mutant p53 Sensitizes Non-Small Cell Lung Cancer Cells to Proteasome Inhibition via Oxidative Stress-Dependent Induction of Mitochondrial Apoptosis
Kranthi Kumar Chougoni, Victoria Neely, Boxiao Ding, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 10, pp. 2685-2698
Open Access | Times Cited: 1
NOXA1-dependent NADPH oxidase 1 signaling mediates angiotensin II activation of the epithelial sodium channel
Elena Mironova, Crystal R. Archer, Aleksandr E. Vendrov, et al.
AJP Renal Physiology (2022) Vol. 323, Iss. 6, pp. F633-F641
Open Access | Times Cited: 6
CREB/Sp1-mediated MCL1 expression and NFκB-mediated ABCB1 expression modulate the cytotoxicity of daunorubicin in chronic myeloid leukemia cells
Jing‐Ting Chiou, Chia‐Hui Huang, Ti-Hsiao Wu, et al.
Toxicology and Applied Pharmacology (2021) Vol. 435, pp. 115847-115847
Closed Access | Times Cited: 8
Targeting CD19-positive lymphomas with the antibody-drug conjugate (ADC) loncastuximab tesirine: preclinical evidence as single agent and as combinatorial approach
Chiara Tarantelli, David N. Wald, Nicolas Munz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Pro-Apoptotic Activity of MCL-1 Inhibitor in Trametinib-Resistant Melanoma Cells Depends on Their Phenotypes and Is Modulated by Reversible Alterations Induced by Trametinib Withdrawal
Mariusz L. Hartman, Paulina Koziej, Katarzyna Kluszczyńska, et al.
Cancers (2023) Vol. 15, Iss. 19, pp. 4799-4799
Open Access | Times Cited: 2
<i>ASXL1</i> mutations are associated with a response to alvocidib and 5-azacytidine combination in myelodysplastic neoplasms
Vladimir Riabov, Qingyu Xu, Nanni Schmitt, et al.
Haematologica (2023)
Open Access | Times Cited: 2
Oncogenic Mutant p53 Sensitizes Non-Small Cell Lung Cancer Cells to Proteasome Inhibition via Oxidative Stress-Dependent Induction of Mitochondrial Apoptosis
Kranthi Kumar Chougoni, Victoria Neely, Boxiao Ding, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Hydroquinone-selected chronic myelogenous leukemia cells are sensitive to chloroquine-induced cytotoxicity via MCL1 suppression and glycolysis inhibition
Jing‐Ting Chiou, Yuan‐Chin Lee, Long‐Sen Chang
Biochemical Pharmacology (2023) Vol. 218, pp. 115934-115934
Closed Access
Page 1

Scroll to top